Melanoma Diagnostics and Therapeutics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The market is segmented by Product Type (Diagnostics and Therapeutics) and Geography

Market Snapshot

melanoma diagnostics and therapeutics market
Study Period: 2018 - 2026
Base Year: 2020
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 15.1 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The melanoma diagnostics and therapeutics market is estimated to show good growth due to the increasing incidences of melanoma cases, rising governments initiatives for early detection and skin cancer treatment and rising technological advancements.

There has been a rapid increase in the melanoma cases that is found to be one of the major causes of morbidity and mortality in the US. Melanoma is one of the most common types of cancer in men and women. Among young adults, it is the second most common invasive cancer. According to WHO statistics, there are more than two million people that develops non-melanoma skin cancer, and around 132,000 people that develop melanoma. Therefore the rising number of cases of melanoma will eventually lead to the high CAGR for the melanoma diagnostics and therapeutics market.

Scope of the Report

As per the scope of the report, melanoma is one of the serious types of skin cancers that develops from pigment-containing cells called as melanocytes. Melanomas typically occur in the skin, but may rarely occur in the mouth, intestines, or eye. In women, they most commonly occur on the legs, while in men they are most common on the back. Moles, brown spots and growths on the skin are found to be the symptoms associated with the disease. The market for melanoma diagnostics and therapeutics is increasing at a significant rate due to an increase in the prevalence of melanoma and improvement in healthcare facilities.

By Product Type
By Diagnostics
Dermatoscopy Devices
Biopsy Devices
By Therapeutics
Biological Therapy
Targeted Therapy
Immune Therapy
North America
United States
United Kingdom
Rest of Europe
Asia Pacific
South Korea
Rest of Asia-Pacific
Middle East and Africa
South Africa
Rest of Middle East and Africa
South America
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Immune Therapy is Anticipated to be the Dominant in Therapeutics Segment during the Forecast Period

Immunotherapy is the use of medicines to stimulate a person immune system to recognize and destroy cancer cells effectively. There are several types of immunotherapies available that can be used to treat melanoma cancer.

Immunotherapy is found to hold the largest share that can be attributed to the effectiveness of drugs used in immunotherapy and an increase in their approvals. There are currently many FDA-approved immunotherapy options for melanoma that helps in the growth of the market. There have also many advances in using immunotherapy drugs known as checkpoint inhibitors to treat melanoma. Thus the strong emerging pipeline for melanoma treatment is expected to drive the immunotherapy segment over the forecast period.

Melanoma Market Trend.png

North America Dominates the Melanoma Diagnostics and Therapeutics Market

North America holds a dominant share of the market owing to the rising incidence of melanoma and other skin cancers cases in the region. According to the Skin Cancer Foundation, one in every five Americans is likely to develop a kind of skin cancer during his/her lifetime. Furthermore, the American cancer society estimates 91,270 new cases of melanoma in the United States in 2018 alone. These statistics highlight the need for drugs that help in the management of melanoma over the coming years.

The United States government has also developed favorable reimbursement policies for treatment of melanoma diseases that is an attempt to fulfil unmet patient needs. This is expected to provide a healthy platform for growth to the North American market. Furthermore, the presence of numerous new players is expected to drive the overall market.

Melanoma DIagnostics and Therapeutics Market - Growth Rate by Region

Competitive Landscape

The market is highly competitive in nature, with many key players involved in market expansion, partnerships, new product development, and R&D to increase market penetration. There are also several products are under clinical trials which are expected to receive approval and thus the market is likely to continue witnessing high competitive rivalry over the forecast period.

Table of Contents


    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Burden of Melanoma Cases

      2. 4.2.2 Rising Governments Initiatives for Early Detection and Skin Cancer Treatment

      3. 4.2.3 Rising Technological Advancements

    3. 4.3 Market Restraints

      1. 4.3.1 High Cost Associated with the Therapy

      2. 4.3.2 Stringent Regulatory Policies

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry


    1. 5.1 By Product Type

      1. 5.1.1 By Diagnostics

        1. Dermatoscopy Devices

        2. Biopsy Devices

      2. 5.1.2 By Therapeutics

        1. Chemotherapy

        2. Biological Therapy

        3. Targeted Therapy

        4. Immune Therapy

    2. 5.2 Geography

      1. 5.2.1 North America

        1. United States

        2. Canada

        3. Mexico

      2. 5.2.2 Europe

        1. Germany

        2. United Kingdom

        3. France

        4. Italy

        5. Spain

        6. Rest of Europe

      3. 5.2.3 Asia Pacific

        1. China

        2. Japan

        3. India

        4. Australia

        5. South Korea

        6. Rest of Asia-Pacific

      4. 5.2.4 Middle East and Africa

        1. GCC

        2. South Africa

        3. Rest of Middle East and Africa

      5. 5.2.5 South America

        1. Brazil

        2. Argentina

        3. Rest of South America


    1. 6.1 Company Profiles

      1. 6.1.1 Abbott Diagnostics

      2. 6.1.2 Amgen, Inc.

      3. 6.1.3 AstraZeneca PLC

      4. 6.1.4 Bayer AG

      5. 6.1.5 Bristol-Myers Squibb

      6. 6.1.6 Daiichi Sankyo Company Limited

      7. 6.1.7 F. Hoffman-La Roche Ltd.

      8. 6.1.8 GlaxoSmithKline PLC

      9. 6.1.9 Merck & Co., Inc

      10. 6.1.10 Novartis AG

    2. *List Not Exhaustive

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Melanoma Diagnostics and Therapeutics Market market is studied from 2018 - 2026.

The Melanoma Diagnostics and Therapeutics Market is growing at a CAGR of 15.1% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

Abbott Laboratories, Amgen, Inc., AstraZeneca Plc, Bristol-Myers Squibb, Novartis AG are the major companies operating in Melanoma Diagnostics and Therapeutics Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!